Nutritional management in the treatment of irritable bowel syndrome (IBS)
DOI:
https://doi.org/10.33448/rsd-v12i6.42135Keywords:
Irritable Bowel Syndrome; FODMAP diet; Gut microbiome.Abstract
Western lifestyle and dietary patterns have contributed to the increased incidence of gastrointestinal diseases in the population. The standard Western diet is characterized by ultra-processed foods, which have a pro-inflammatory profile and contribute for the intestinal microbiota imbalance. Of the main gastrointestinal disorders, irritable bowel syndrome (IBS) stands out, a chronic intestinal disorder that already affects a significant portion of the population and whose main symptoms are abdominal pain and discomfort. The main objective of this study is to analyze the main nutritional strategies cited in the literature for treating and managing IBS symptoms, through an integrative literature review. The main articles published in the years 2018 to 2023 were collected and evaluated, and the information gathered in the reading was synthesized in this study. In view of the information collected, the low-FODMAP diet has been shown to be the most effective approach to treating the gastrointestinal symptoms of IBS, reducing the severity of the disease and improving the symptoms of abdominal pain, bloating, and diarrhea in patients. It is emphasized that the diet must be conducted by a specialized nutritionist for proper implementation of the protocol, taking into account the individualities of each patient. IBS is not a syndrome that should be treated in isolation, as it is not triggered by food alone, a multidisciplinary treatment is required.
References
Black, C. J., & Ford, A. C. (2020). Global burden of irritable bowel syndrome: trends, predictions and risk factors. Nature reviews Gastroenterology & hepatology, 17(8), 473-486.
Black, C. J., Staudacher, H. M., & Ford, A. C. (2022). Efficacy of a low FODMAP diet in irritable bowel syndrome: systematic review and network meta-analysis. Gut, 71(6), 1117-1126.
Böhn, L., Störsrud, S., Liljebo, T., Collin, L., Lindfors, P., Törnblom, H., & Simrén, M. (2015). Diet low in FODMAPs reduces symptoms of irritable bowel syndrome as well as traditional dietary advice: a randomized controlled trial. Gastroenterology, 149(6), 1399-1407.
Dimidi, E., & Whelan, K. (2020). Food supplements and diet as treatment options in irritable bowel syndrome. Neurogastroenterology & Motility, 32(8), e13951.
Dionne, J., Ford, A. C., Yuan, Y., Chey, W. D., Lacy, B. E., Saito, Y. A., ... & Moayyedi, P. (2018). A systematic review and meta-analysis evaluating the efficacy of a gluten-free diet and a low FODMAPs diet in treating symptoms of irritable bowel syndrome. Official journal of the American College of Gastroenterology| ACG, 113(9), 1290-1300.
Gomes, Cátia Sofia Pinheiro. (2019). Síndrome do intestino irritável e microbiota intestinal. [Tese de Doutorado]. Universidade do Porto.
Krieger-Grübel, C., Hutter, S., Hiestand, M., Brenner, I., Güsewell, S., & Borovicka, J. (2020). Treatment efficacy of a low FODMAP diet compared to a low lactose diet in IBS patients: A randomized, cross-over designed study. Clinical nutrition ESPEN, 40, 83-89.
Mohseni, F., Agah, S., Ebrahimi-Daryani, N., Taher, M., Nattagh-Eshtivani, E., Karimi, S., ... & Hekmatdoost, A. (2022). The effect of low FODMAP diet with and without gluten on irritable bowel syndrome: A double blind, placebo controlled randomized clinical trial. Clinical nutrition ESPEN, 47, 45-50.
Nordin, E., Brunius, C., Landberg, R., & Hellström, P. M. (2022). Fermentable oligo-, di-, monosaccharides, and polyols (FODMAPs), but not gluten, elicit modest symptoms of irritable bowel syndrome: a double-blind, placebo-controlled, randomized three-way crossover trial. The American Journal of Clinical Nutrition, 115(2), 344-352.
Paduano, D., Cingolani, A., Tanda, E., & Usai, P. (2019). Effect of three diets (low-FODMAP, gluten-free and balanced) on irritable bowel syndrome symptoms and health-related quality of life. Nutrients, 11(7), 1566.
Rome Foundation. (2016). Rome IV Criteria. https://theromefoundation.org/rome-iv/rome-iv-criteria.
Schumann, D., Klose, P., Lauche, R., Dobos, G., Langhorst, J., & Cramer, H. (2018). Low fermentable, oligo-, di-, mono-saccharides and polyol diet in the treatment of irritable bowel syndrome: A systematic review and meta-analysis. Nutrition, 45, 24-31.
Shaikh, S. D., Sun, N., Canakis, A., Park, W. Y., & Weber, H. C. (2023). Irritable Bowel Syndrome and the Gut Microbiome: A Comprehensive Review. Journal of Clinical Medicine, 12(7), 2558.
Sociedade Brasileira de Motilidade Digestiva e Neurogastroenterologia. (2019, 19 de março). Síndrome do Intestino Irritável (SII). http://www.sbmdn.org.br/sindrome-do-intestino-irritavel-sii.
Silva, M. T., Leite, F. M. M., Santiago, F. V. P., de Albuquerque, Í. G. S., Brito, A. P. S. O., & Garcia, H. C. R. (2020). Diagnóstico e tratamento da síndrome do intestino irritável: revisão sistemática. Pará Research Medical Journal, 4, 0-0.
Staudacher, Heidi M. et al. (2021). Gut microbiota associations with diet in irritable bowel syndrome and the effect of low FODMAP diet and probiotics. Clinical Nutrition, v. 40, n. 4, p. 1861-1870.
So, D., Loughman, A., & Staudacher, H. M. (2022). Effects of a low FODMAP diet on the colonic microbiome in irritable bowel syndrome: a systematic review with meta-analysis. The American Journal of Clinical Nutrition, 116(4), 943-952.
van Lanen, A. S., de Bree, A., & Greyling, A. (2021). Efficacy of a low-FODMAP diet in adult irritable bowel syndrome: a systematic review and meta-analysis. European journal of nutrition, 60, 3505-3522.
Whittemore, R., & Knafl, K. (2005). The integrative review: updated methodology. Journal of Advanced Nursing, 52(5), 546–553.
Więcek, M., Panufnik, P., Kaniewska, M., Lewandowski, K., & Rydzewska, G. (2022). Low-FODMAP Diet for the Management of Irritable Bowel Syndrome in Remission of IBD. Nutrients, 14(21), 4562.
Zahedi, M. J., Behrouz, V., & Azimi, M. (2018). Low fermentable oligo‐di‐mono‐saccharides and polyols diet versus general dietary advice in patients with diarrhea‐predominant irritable bowel syndrome: a randomized controlled trial. Journal of gastroenterology and hepatology, 33(6), 1192-1199.
Zeeshan, M. H., Vakkalagadda, N. P., Sree, G. S., kishore Anne, K., Parkash, O., Fawwad, S. B. U., ... & Hasan, M. (2022). Irritable bowel syndrome in adults: Prevalence and risk factors. Annals of Medicine and Surgery, 81, 104408.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Wendy Tsui; Geovana Chagas dos Santos; Simone Gonçalves de Almeida
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
